Meanwhile, patients carrying LRRK2 G2019S at visit 1 showed a trend of downregulation of longer genes compared to shorter genes, but the test was not statistically significant (median length of upregulated genes, 12,216 bp; median length of downregulated genes, 17,417 bp; Wilcoxon P = 0.2509) (Extended Data Fig. 7b,c ).
← all excerpts
A blood-based DNA damage signature in patients with Parkinson's disease is associated with disease progression.
1
—
—